Notes

Updates, corrections and superseded versions

10 Sep 2018 - Apparent consumption of alcohol data updated with 2016–17 numbers resulting in updates to the summary webpage (tableau image for alcohol consumption), Alcohol webpage (availability section and Figure ALCOHOL1) and supplementary Table S2.3.

13 Dec 2018 - Release of updated content, data tables and tableau.
Previous versions of data tables released 14 August 2018: Alcohol, tobacco and other drugs, Impacts and Populations.

30 Jan 2019 - National Health Survey data updated with 2017–18 numbers resulting in updates to the Tobacco webpage (consumption and tobacco smoking by age and sex sections) and Alcohol webpage (consumption, lifetime risk, single occasion risk sections) and supplementary tables S2.27 and S2.29.
Previous versions of data tables released 13 December 2018: Alcohol, tobacco and other drugs.

15 Mar 2019 - Updated wastewater analysis included resulting in updates to the Harm minimisation webpage, Drug types webpages and the Summary of main data sources used in this report webpage.

25 Jul 2019 - Release of updated content, data tables and tableau.
Previous versions of data tables released 30 January 2019: Alcohol, tobacco and other drugs, Impacts and Populations.

6 Aug 2019 - Revised National Health Survey data in Table S2.26 resulting in revisions on the Alcohol webpage (consumption and lifetime risk). Previous version of the data tables released 25 July 2019: Alcohol, tobacco and other drugs.

23 Sep 2019 - Release of updated content, data tables and tableau.
Previous versions of the data tables released 6 August 2019: Alcohol, tobacco and other drugs, Impacts and Populations.

2 Oct 2019 - Rates presented in Table S1.8 have been amended for all years for the categories: ‘Antidepressants and antipsychotics’; ‘Volatile solvents’; ‘Multiple drug use’; ‘Unspecified drug use and other drugs not elsewhere classified’; and ‘Fetal and perinatal conditions’.
Previous version of the data tables released on 23 September 2019: Impacts.

8 Nov 2019 - Release of updated content, data tables and tableau. 

Previous versions of data tables released 23 September 2019: Alcohol, tobacco and other drugs, and Populations. Previous versions of data table released 18 October 2019: Impacts

19 Dec 2019 - Release of updated content, data tables and tableau. Previous versions of data tables released 23 September 2019: Alcohol, tobacco and other drugs, and Populations. Previous versions of data table released 18 October 2019: Impacts

21 Jan 2020 - Release of updated content, data tables and tableau. Previous versions of data tables released 19 December 2019: Alcohol, tobacco and other drugs, and Populations. Previous versions of data table released 18 October 2019: Impacts

23 April 2020 - Release of updated content, data tables and tableau. Previous versions of data tables released on 21 January 2020: Impacts, Alcohol, tobacco and other drugs, and Populations.  

26 June 2020 - Release of updated content, data tables and tableau. Previous versions of data tables released on 23 April 2020: Alcohol, tobacco and other drugs, and Populations.

Pages updated at 26 June 2020 release

Section

Page updated

Data sources

Section 1 – Harm minimisation

Demand reduction – Treatment

Alcohol and other drug treatment services in Australia 2018–19

Section 1 – Harm minimisation

Harm reduction – Minimising risky behaviours

Penington Institute: Saving Lives: Australian naloxone access model

Section 1 – Harm minimisation

Harm reduction – Minimising risky behaviours

Illicit Drug Reporting System

Section 2 – Impacts

Impact of COVID-19 on alcohol and other drug use

New section; content sourced from Department of Health, CBA, ABS, Foundation for Alcohol Research and Education and the Burnet Institute

Section 2 – Impacts

Impact of COVID-19 on alcohol and other drug use

New section; content sourced from Department of Health, CBA, ABA, ANU, ABS, FARE, Burnet Institute

Section 2 – Impacts

Health impacts – Drug-induced deaths

AIHW analysis of the National Mortality Database 2018

Section 2 – Impacts

Health impacts – Pregnancy complications 

Australia’s mothers and babies 2018

Section 2 – Impacts

Social impacts – Family, domestic and sexual violence

The role of illicit drug use in family and domestic violence in Australia.

Section 2 – Impacts

Social impacts – Family, domestic and sexual violence

AIC: Methamphetamine dependence and domestic violence among police detainees

 

Section 2 – Impacts

Social impacts – Homicide

Homicide in Australia 2016-17 and Homicide in Australia 2017-18

Section 2 – Impacts

Social impacts – Illicit drug use within families

The Household, Income and Labour Dynamics in Australia Survey: Selected Findings from Waves 1 to 17.

Section 2 – Impacts

Economic impacts

Quantifying the social costs of pharmaceutical opioid misuse & illicit opioid use to Australia in 2015/16; content also revised to focus on NDRI series

Section 3 – Drug types

Tobacco – Consumption

Retail value and volume of the Australian tobacco market

ATO Illicit tobacco

TGA Electronic cigarettes

Section 3 – Drug types

Tobacco – Consumption

Tobacco – Resources and further information

DoH policy and regulatory approach to e-cigarettes in Australia

Section 3 – Drug types

Tobacco – Tobacco smoking in pregnancy

 

Tobacco – Aboriginal and Torres Strait Islander people

Australia’s mothers and babies 2018

Section 3 – Drug types

Tobacco – Treatment

Alcohol – Treatment

Cannabis – Treatment

Meth/amphetamine and other stimulants – Treatment

Non-medical use of pharmaceutical drugs – Treatment

Illicit opioids, including heroin – Treatment

Alcohol and other drug treatment services in Australia 2018–19

Section 3 – Drug types

Cannabis – Harms

Meth/amphetamine and other stimulants – Harms

Non-medical use of pharmaceutical drugs – Harms

Illicit opioids, including heroin – Harms

AIHW analysis of the National Mortality Database 2018

Section 4 – Priority populations

Aboriginal and Torres Strait Islander people –

Tobacco smoking

Alcohol consumption

NATSIHS 2018–19 data included in trend tables

Section 4 – Priority populations

Aboriginal and Torres Strait Islander people – Tobacco smoking in pregnancy

Australia’s mothers and babies 2018

Section 4 – Priority populations

Aboriginal and Torres Strait Islander people – Treatment

Older people – Treatment

People from culturally and linguistically diverse backgrounds – Treatment

eople in contact with the criminal justice system – Treatment

Younger people – Treatment

Alcohol and other drug treatment services in Australia 2018–19

Section 4 – Priority populations

People in contact with the criminal justice system – Young people under youth justice supervision

Youth Justice in Australia 2018–19

Technical notes

National Mortality Database

AIHW analysis of the National Mortality Database 2018

Data quality

New data sources for reporting on the impact of COVID-19 have been included

CBA, ANU, ABS, FARE, Burnet Institute

Pages updated at 23 April 2020 update

Section

Page updated

Data sources

Section 1 – Harm minimisation

Supply reduction – Wastewater analysis

National Wastewater Drug Monitoring Program Report 9

Section 2 – Impacts

Social impacts – Victimisation

ABS Crime Victimisation 2018–19

Section 3 – Drug types

Tobacco – Consumption

Alcohol – Consumption

Cannabis – Consumption

Meth/amphetamine and other stimulants – Consumption

Non-medical use of pharmaceuticals – Consumption

Illicit opioids, including heroin – Consumption

Illicit opioids, including heroin – Treatment

New and emerging psychoactive substances – Synthetic cannabinoids

National Wastewater Drug Monitoring Program Report 9

Section 3 – Drug types

Illicit opioids, including heroin - Treatment

NOPSAD 2019

Section 4 – Priority populations

Aboriginal and Torres Strait Islander people – Health and harms

Older people – Health and harms

NOPSAD 2019

Section 4 – Priority populations

People in contact with the criminal justice system - Police

ABS Recorded Crime – Offenders 2018–19

Section 4 – Priority populations

People in contact with the criminal justice system - Courts

ABS Criminal Courts 2018–19

Pages updated at 21 January 2020 update

Section

Page updated

Data sources

Section 2 – Impacts

Social impacts – Contact with the criminal justice system  

Drug use monitoring in Australia: Drug use among police detainees, 2018

Section 2 – Impacts

Social impacts – Homicide

Homicide in Australia 2015–16

Section 2 – Impacts

Health impacts – Drug-induced deaths

Trends in drug-induced deaths in Australia, 1999-2018

Section 2 – Impacts

Health impacts – Injury and hospitalisation

Trends in drug-related hospitalisations in Australia, 1999-2018

Section 3 – Drug types

Alcohol – Policy context

National Alcohol Strategy 2019 – 2028

Section 3 – Drug types

Tobacco – At risk groups

Alcohol – At risk groups

National Aboriginal and Torres Strait Islander Health Survey, 2018-19

Section 3 – Drug types

Cannabis – At risk groups

Meth/amphetamine and other stimulants – Consumption

Non-medical use of pharmaceutical drugs – At risk groups

Illicit opioids, including heroin

Drug use monitoring in Australia: Drug use among police detainees, 2018

Section 3 – Drug types

Cannabis – Harms – Deaths

Meth/amphetamine and other stimulants – Harms – Deaths 

Non-medical use of pharmaceutical drugs – Harms – Deaths

Illicit opioids, including heroin – Harms – Deaths

Trends in drug-induced deaths in Australia, 1999-2018

Section 4 – Populations

Aboriginal and Torres Strait Islander people 

National Aboriginal and Torres Strait Islander Health Survey, 2018-19

Section 4 – Populations

People in contact with the criminal justice system – Alcohol consumption

People in contact with the criminal justice system – Illicit drug use

Drug use monitoring in Australia: Drug use among police detainees, 2018

Section 4 – Populations

People in contact with the criminal justice system–Corrective services

Prisoners in Australia, 2019

Pages updated at 19 December 2019 release

Section

Page updated

Data sources

Interactive data  

Treatment

Pharmacotheraphy in Australia

Section 2 – Impacts

Health impacts – Hospitalisations

AIHW analysis of the National Hospital Morbidity Database
2017–18

Section 3 – Drug types

Alcohol – Harms

Cannabis – Harms

Non-medical use of pharmaceuticals – Harms 

AIHW analysis of the National Hospital Morbidity Database
2017–18

Section 4 – Populations

People experiencing homelessness 

Specialist homelessness services annual report 2018–19

Pages updated at 8 November 2019 update

Section

Page updated

Data sources

Section 1 – Harm minimisation

Supply reduction - Prohibited substances

Illicit Drug Reporting System (IDRS)

Ecstasy and related Drugs Reporting System (EDRS)

Section 1 – Harm minimisation

Supply reduction – Wastewater analysis

National Wastewater Drug Monitoring Program Report 8

Methylamphetamine supply reduction–measures of effectiveness

Section 2 – Impacts

Health impacts – Burden of disease

Burden of tobacco use in Australia: Australian Burden of Disease Study 2015

Section 2 – Impacts

Health impacts – Injection-related harms

Health impacts – Overdose

Illicit Drug Reporting System (IDRS)

Section 2 – Impacts

Health impacts – Injection-related harms

ABS Causes of Death, 2018

Section 2 – Impacts

Health impacts – Mental illness

Health impacts – Overdose

Ecstasy and related Drugs Reporting System (EDRS)

Section 2 – Impacts

Social impacts – Risky behaviours and criminal activity 

Illicit Drug Reporting System (IDRS)

Ecstasy and related Drugs Reporting System (EDRS)

Section 2 – Impacts

Economic impacts

Identifying the Social Costs of Tobacco Use to Australia in 2015/16

Section 3 – Drug types

Tobacco – Harms

Burden of tobacco use in Australia: Australian Burden of Disease Study 2015

Section 3 – Drug types

Tobacco – Consumption

Tobacco – Geographic trends

Alcohol – Consumption

Cannabis – Consumption

Meth/amphetamine and other stimulants – Geographic trends

Non-medical use of pharmaceuticals – Consumption

Non-medical use of pharmaceuticals – At risk groups

Illicit opioids including heroin – consumption

New (and emerging) psychoactive substances – Synthetic cannabinoids

National Wastewater Drug Monitoring Program Report 8

Section 3 – Drug types

Cannabis – Availability

Cannabis – At risk groups

Cannabis – People who inject drugs

Meth/amphetamine and other stimulants – Availability

Non-medical use of pharmaceuticals – At risk groups

Non-medical use of pharmaceuticals – At risk groups

Illicit opioids including heroin – Availbility

Illicit opioids including heroin – At risk groups

Illicit Drug Reporting System (IDRS)

Section 3 – Drug types

Cannabis – Availability

Meth/amphetamine and other stimulants – Availability

Meth/amphetamine and other stimulants – Consumption

New and emerging psychoactive substances – Consumption 

Ecstasy and related Drugs Reporting System (EDRS)

Section 3 – Drug types

Meth/amphetamine and other stimulants – Availability

Methylamphetamine supply reduction–measures of effectiveness

Section 3 – Drug types

Non-medical use of pharmaceuticals – Harms

Illicit opioids including heroin – Consumption

Illicit opioids including heroin – Harms

ABS Causes of Death, 2018

Section 4 – Populations

People experiencing homelessness – Illicit drug use

People in contact with the criminal justice system – Illicit drug use

People who inject drugs – Methamphetamine

People who inject drugs – Heroin

People who inject drugs – Burden of disease and injury 

Illicit Drug Reporting System (IDRS)

Section 4 – Populations

People with mental health conditions – Illicit drug use

Ecstasy and related Drugs Reporting System (EDRS)

Pages updated at 23 September 2019 update

Section

Page updated

Data sources

Section 1 – Harm minimisation

Demand reduction – Alcohol consumption

OECD Health Statistics 2019

Apparent consumption of alcohol

Section 1 – Harm minimisation

Supply reduction – Drug seizures

Illicit Drug Data Report 2017–18

Section 2 – Impacts

Social impacts – Contact with the criminal justice system

Illicit Drug Data Report 2017–18

Section 2 – Impacts

Social impacts – Driving under the influence of alcohol and other drugs

Road Trauma Australia—Annual Summaries

Section 2 – Impacts

Health impacts – Injection-related harms

Australian NSP Survey National Data Report 2014 – 2018: Prevalence of HIV, HCV and injecting and sexual behaviour among NSP attendees

Section 2 – Impacts

Economic impacts

The Social Costs of Methamphetamine in Australia 2013/14

Section 3 – Drug types

Alcohol – Availability

Apparent consumption of alcohol

Section 3 – Drug types

Alcohol – Risky behaviours

Road Trauma Australia—Annual Summaries

Section 3 – Drug types

Cannabis – Availability

Cannabis – At risk groups

Meth/amphetamine and other stimulants – Availability

Meth/amphetamine and other stimulants – Consumption

Non-medical use of pharmaceuticals – Availability

Non-medical use of pharmaceuticals – People engaged in the criminal justice system

Illicit opioids including heroin – Availability

Illicit opioids including heroin – People engaged in the criminal justice system

New (and emerging) psychoactive substances – Availability

Illicit Drug Data Report 2017–18

Section 4 – Populations

People identifying as lesbian, gay, bisexual, transgender, intersex or queer – People who inject drugs

People who inject drugs – Methamphetamine

People who inject drugs – Heroin

People who inject drugs – Pharmaceutical opioids

People who inject drugs – Injecting risk behaviours

People who inject drugs –Injection-related health problems

People who inject drugs – Needle and syringe programs

Australian NSP Survey National Data Report 2014 – 2018: Prevalence of HIV, HCV and injecting and sexual behaviour among NSP attendees

Section 4 – Populations

Aboriginal and Torres Strait Islander people – Health and harms

Australia’s Annual Overdose Report 2019

Pages updated at 25 July 2019 release

Section

Page updated

Data sources

Section 1 – Harm minimisation

Supply reduction – Wastewater analysis

National Wastewater Drug Monitoring Program, 2019

Section 1 – Demand reduction

Demand reduction – Illicit drug use and non-medical use of pharmaceutical drugs

UNODC – World Drug Report 2018

Section 1 – Demand reduction

Demand reduction – Treatment

Alcohol and other drug use in regional and remote Australia: consumption, harms and access to treatment 2016–17 

Section 1 – Demand reduction

Demand reduction – Treatment

Alcohol and other Drug Treatment Services National Minimum Data Set
2017–18

Section 1 – Demand reduction

Demand reduction – Treatment

UNODC – World drug report 2019

Section 2 – Impacts

Health impacts – Overdose

AMBO-Stats 2017–18

Section 2 – Impacts

Health impacts – Drug-induced deaths

Alcohol and other drug use in regional and remote Australia: consumption, harms and access to treatment 2016–17 

Section 2 – Impacts

Health impacts – Drug-induced deaths

Trends in drug-induced deaths in Australia 1997–2017

Section 2 – Impacts

Health impacts – Burden of disease, Injection-related harms

Australian Burden of Disease Study: impact and causes of illness and death in Australia 2015

Section 2 – Impacts

Social impacts – Driving under the influence of alcohol and other drugs

Crime Victimisation Australia, 2017–18

Section 2 – Impacts

Social impacts – Contact with the Criminal Justice System

Drug use monitoring in Australia: Drug use among police detainees, 2017

Section 3 – Drug types

Tobacco – Treatment

Alcohol – Treatment

Cannabis – Treatment

Methamphetamines and other stimulants – Amphetamines, ecstasy and cocaine

Non-medical use of pharmaceutical drugs – Treatment

Illicit opioids (heroin) – Treatment

Alcohol and other Drug Treatment Services National Minimum Data Set
2017–18

 

Section 3 – Drug types

Alcohol – Geographic trends

Cannabis – Geographic trends

Methamphetamine and other stimulants – Geographic trends

Alcohol and other drug use in regional and remote Australia: consumption, harms and access to treatment 2016–17 

Section 3 – Drug types

 

Cannabis – Consumption

Non-medical use of pharmaceutical drugs – Availability

New (and emerging) psychoactive substances

UNODC – World Drug Report 2019

Section 3 – Drug types

Tobacco – Consumption and geographic trends

Alcohol – Consumption

Cannabis – Consumption

Methamphetamine and other stimulants – Geographic trends

Non-medical use of pharmaceuticals – Consumption and at risk groups

New (and emerging) psychoactive substances

National Wastewater Drug Monitoring Program, 2019

Section 3 – Drug types

Cannabis – Treatment

Non-medical use of pharmaceutical drugs – Treatment

Illicit opioids including heroin – Treatment

Alcohol and other Drug Treatment Services National Minimum Data Set
2017–18

Section 3 – Drug types

Tobacco – Key findings

Alcohol – Younger people

Cannabis – Use by age and sex

Australian Secondary School Students’ Use of Tobacco, Alcohol, Over-the-Counter Drugs, and Illicit Substances, 2017

Section 3 – Drug types

Cannabis – People engaged with the criminal justice system

Methamphetamine and other stimulants – Consumption

The Health of Australia’s Prisoners 2018

Section 3 – Drug types

Illicit opioids – Treatment

National Opioid Pharmacotherapy Statistical Annual Data Collection (NOPSAD) 2018

Section 3 – Drug types

Cannabis – People engaged with the criminal justice system

Methamphetamines and other stimulants – Meth/amphetamine, ecstasy, cocaine

Non-medical use of pharmaceutical drugs – at risk groups

Illicit opioids including Heroin – At risk groups

Drug use monitoring in Australia: Drug use among police detainees, 2017

Section 3 – Drug types

Tobacco – Harms

Alcohol – Harms, at risk groups

Cannabis – Harms

Methamphetamines and other stimulants – Harms

Illicit opioids including Heroin – Harms

Australian Burden of Disease Study: impact and causes of illness and death in Australia 2015

Section 3 – Drug types

Methamphetamines and other stimulants – Harms

Non-medical use of pharmaceutical drugs – Harms

Illicit opioids including Heroin – Harms

Trends in drug-induced deaths in Australia, 1997–2017

Section 4 – Populations

Aboriginal and Torres Strait Islander people – Treatment

Older people – Treatment

Younger people – Treatment

Alcohol and other Drug Treatment Services National Minimum Data Set
2017–18

Section 4 – Populations

Aboriginal and Torres Strait Islander people – Illicit drug use

Aboriginal and Torres Strait Islander Adolescent and Youth Health and Wellbeing 2018

Section 4 – Populations

Aboriginal and Torres Strait Islander people – treatment

National Opioid Pharmacotherapy Statistical Annual Data Collection (NOPSAD) 2018

Section 4 – Populations

Aboriginal and Torres Strait Islander people – treatment

Alcohol and other drug use in regional and remote Australia: consumption, harms and access to treatment 2016–17 

Section 4 – Populations

People experiencing homelessness – alcohol consumption, health and harms

Specialist Homelessness Services Annual Report 2017–18

Section 4 – Populations

Older people – treatment

National Opioid Pharmacotherapy Statistical Annual Data Collection (NOPSAD) 2018

Section 4 – Populations

People in contact with the criminal justice system – tobacco smoking and health and harms

The Health of Australia’s Prisoners 2018

Section 4 – Populations

People in contact with the criminal justice system – Young people under youth justice supervision

Youth justice in Australia 2017–18

Section 4 – Populations

People in contact with the criminal justice system – Corrective services

Prisoners in Australia, 2018

Section 4 – Populations

People in contact with the criminal justice system – Police

Recorded Crime – Offenders, 2017–18

Section 4 – Populations

People in contact with the criminal justice system – Courts

Criminal Courts Australia, 2017–18

Section 4 – Populations

People in contact with the criminal justice system – Alcohol consumption

People in contact with the criminal justice system – Illicit drug consumption

Drug use monitoring in Australia: Drug use among police detainees, 2017

Section 4 – Populations

People with mental health conditions – Tobacco smoking

Tobacco in Australia: Facts and Issues 2018

Section 4 – Populations

Younger people – Tobacco smoking, geographic trends, alcohol consumption, cannabis use and mental health

Australian Secondary School Students’ Use of Tobacco, Alcohol, Over-the-Counter Drugs, and Illicit Substances, 2017

Section 4 – Populations

Younger people – Tobacco smoking (daily smoking)

Aboriginal and Torres Strait Islander Adolescent and Youth Health and Wellbeing 2018

Section 4 – Populations

People who inject drugs – Drug type

Needle and Syringe Program National Minimum Data Collection, 2018

Section 4 – Populations

People who inject drugs

UNODC – World Drug Report 2019

Section 4 – Populations

Older people – Tobacco smoking

Younger people – Health and harms

People who inject drugs – Health and harms

Australian Burden of Disease Study: impact and causes of illness and death in Australia 2015

Pages updated at 13 December 2018 release

Section

Page updated

Data sources

Section 1 – Harm minimisation

Supply reduction – Drug seizures

Illicit Drug Data Report 2016–17

Section 1 – Harm minimisation

Supply reduction – Prohibited substances

Illicit Drug Reporting System (IDRS)

Section 1 – Harm minimisation

Supply reduction – Wastewater analysis

National Wastewater Drug Monitoring Program

Section 1 – Harm minimisation

Demand reduction – Alcohol consumption.

Causes of Death, 2017

Section 2 – Impacts

Health impacts – Pregnancy complications

Australia’s mothers and babies 2016

Section 2 – Impacts

Health impacts – Injury and hospitalisation

Opioid harm in Australia: prevalence, trends and comparisons between Australia and Canada

Section 2 – Impacts

Health impacts – Injection-related harms

Illicit Drug Reporting System (IDRS)

Australian Needle Syringe National Data report 2013–2017

Section 2 – Impacts

Health impacts – Drug-induced deaths

Causes of Death, 2017

Australia’s Annual Overdose Report 2018

Section 2 – Impacts

Social impacts – Contact with the criminal justice system

Illicit Drug Data Report 2016–17

Section 2 – Impacts

Social impacts – Risky behaviours and criminal activity

The Ecstasy and related Drugs Reporting System (EDRS)

Crime Victimisation, Australia, 2016–17

Section 3 – Drug types

 

Alcohol – Availability

Apparent Consumption of Alcohol, 2016–17

Section 3 – Drug types

 

Alcohol – Harms (Deaths, illness and injury - new)

Causes of Death, 2017

Section 3 – Drug types

Alcohol – Risky behaviours

Road trauma Australia 2017 statistical summary

Section 3 – Drug types

Tobacco – Harms

Australia’s mothers and babies 2016

Section 3 – Drug types Section 3 – Drug types Section 3 – Drug types

Cannabis; Methamphetamine and other stimulants; Illicit opioids (heroin); New (and emerging) psychoactive substances — Availability

 

Illicit Drug Data Report 2016–17

Section 3 – Drug types

Cannabis — At-risk groups Methamphetamine and other stimulants – Availability. Non-medical use of pharmaceutical drugs – At-risk groups. Illicit opioids (heroin) – Availability; At-risk groups

Illicit Drug Reporting System (IDRS)

Section 3 – Drug types

Non-medical use of pharmaceutical drugs – Availability, Harms (Deaths, illness and injury), Illicit opioids (heroin) – Availability, Harms

Opioid harm in Australia: Prevalence, trends and comparisons between Australia and Canada

Section 3 – Drug types

Methamphetamine and other stimulants – Harms (Deaths)

Opioid, amphetamine and cocaine-induced deaths in Australia

Section 3 – Drug types

Alcohol, Cannabis, Non-medical use of pharmaceutical drugs, Illicit Opioids (Heroin) - Deaths

Australia’s Annual Overdose Report 2018

Section 4 – Populations

Aboriginal and Torres Strait Islander People — Tobacco smoking.

Australia’s mothers and babies 2016

Section 4 – Populations

Aboriginal and Torres Strait Islander People – Health and harms.

Aboriginal and Torres Strait Islander health organisations: Online Services report – key results 2016–17

Section 4 – Populations

People with mental health conditions — Illicit drug use.

The Ecstasy and related Drugs Reporting System (EDRS)

Section 4 – Populations

Homeless people — Illicit drug use, People in contact with the criminal justice system — Illicit drug use, People who inject drugs

Illicit Drug Reporting System (IDRS)

Section 4 – Populations

Homeless people — Illicit drug use, People in contact with the criminal justice system — Illicit drug use, People who inject drugs

Australian Needle Syringe National Data report 2013–2017